Partner Clyde Tinnen was quoted in a Reorg article, “Healthcare Mergers Dwindle Despite Increase in Sector Activity,” about an expected decline in industry deals for both health care providers and pharmaceutical companies in light of the coronavirus pandemic.
Tinnen said enforcement changes made by regulators so far in response to the spread of the coronavirus appear aimed at collaboration and conduct rather than M&A. For industry players contemplating uncertain territories, he said, “the agencies will be there to guide them on how much information can be shared without divulging prohibited competitive information such as pricing data.”
(Subscription required.)
People
Related News
26 April 2024
In the News
IP Laterals Ngai Zhang and Drew Schulte Make Headlines with Move to Foley
Foley & Lardner LLP partners Ngai Zhang and Drew Schulte are featured across legal press for their recent move to the firm, including in the Law360 article, “Foley & Lardner Gains Two Perkins Coie IP Partners.”
24 April 2024
In the News
Judith Waltz Discusses Nursing Home Staffing Mandate, Potential Legal Challenges
Foley & Lardner LLP partner Judith Waltz offers insight on a new nursing home staffing rule from the U.S. Department of Health and Human Services and its impact on the industry in the Bloomberg Law article, “Nursing Homes, HHS on Collision Path Over Staffing Mandate.”
23 April 2024
In the News
David Sanders Discusses Lessons Learned from General Counsel Leadership Program
Foley & Lardner LLP partner David Sanders recently joined a panel discussion with members of The Vanguard Network’s General Counsels Advisory Group to discuss the evolving role of the general counsel.